Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo's score of 36 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Daiichi Sankyo reported total carbon emissions of approximately 46,028,740,000 kg CO2e globally, with 63,004,000 kg CO2e from Scope 1 and 2,173,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions by fiscal year 2050 for both Scope 1 and Scope 2 emissions. This long-term target reflects a significant commitment to reducing its carbon footprint and aligns with global sustainability goals. In Japan, Daiichi Sankyo's emissions for 2023 were approximately 65,300,000 kg CO2e, comprising 63,004,000 kg CO2e from Scope 1 and 2,173,000 kg CO2e from Scope 2. The company has demonstrated a proactive approach to climate action, focusing on reducing emissions across its operations while maintaining transparency in its reporting. Daiichi Sankyo's commitment to achieving net-zero emissions by 2050 underscores its dedication to environmental sustainability and responsible corporate practices.
Access structured emissions data, company-specific emission factors, and source documents
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 217,257,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 304,293,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.